Porteføljevirksomheder
Retrovec ApS
Kategori
Biotek/medico
Forretningsområde
The company is presently involved in the development of an HIV vaccine as well as cancer therapy.
Projektbeskrivelse
With its founders’ strong background in the use of retroviral vector technology, Retrovec has developed a portfolio of patents relevant for the use of retroviral vectors in gene therapy, as well as for the development of vaccine in the prevention of HIV/AIDS.
With its founders’ strong background in the use of retroviral vector technology, Retrovec has developed a portfolio of patents relevant for the use of retroviral vectors in gene therapy, as well as for the development of vaccine in the prevention of HIV/AIDS.
FORRETNINGSOMRÅDE
Retrovec ApS
Åbogade 15, 8200 Århus N
Kontakt Jørn Falch
Telefon 8620 5065
jf@oei.dk
Åbogade 15, 8200 Århus N
Kontakt Jørn Falch
Telefon 8620 5065
jf@oei.dk
FAKTA
CVR-nummer: 27520537
Etableringsår: 2004
Østjysk Innovation · Incuba Science Park · Åbogade 15 · DK-8200 Aarhus N · T +45 87 34 58 90